|
APBB2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62447832963153E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
1.62436730732907E-12 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
7.396300E-04 |
| Stage1-vs-Stage2 |
3.134200E-01 |
| Stage1-vs-Stage3 |
5.693200E-01 |
| Stage1-vs-Stage4 |
3.010800E-01 |
| Stage2-vs-Stage3 |
7.049800E-01 |
| Stage2-vs-Stage4 |
2.079200E-01 |
| Stage3-vs-Stage4 |
2.610800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62447832963153E-12 |
| Normal-vs-AfricanAmerican |
1.62525548574877E-12 |
| Normal-vs-Asian |
1.63860000013116E-08 |
| Caucasian-vs-AfricanAmerican |
1.972640E-01 |
| Caucasian-vs-Asian |
8.361800E-01 |
| AfricanAmerican-vs-Asian |
7.748000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
1.62436730732907E-12 |
| Male-vs-Female |
3.851900E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.39420003214741E-09 |
| Normal-vs-Extreme_Weight |
1.62447832963153E-12 |
| Normal-vs-Obese |
<1E-12 |
| Normal-vs-Extreme_Obese |
<1E-12 |
| Normal_Weight-vs-Extreme_Weight |
1.084390E-01 |
| Normal_Weight-vs-Obese |
4.467000E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.062300E-02 |
| Extreme_Weight-vs-Obese |
5.751500E-02 |
| Extreme_Weight-vs-Extreme_Obese |
9.696200E-02 |
| Obese-vs-Extreme_Obese |
2.158800E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.08519859765011E-11 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
<1E-12 |
| Normal-vs-Age(81-100Yrs) |
5.21804821573824E-15 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.501600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.491200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.950000E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.551600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.722000E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.013600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.62447832963153E-12 |
| Normal-VS-Type2 PRCC |
1.62436730732907E-12 |
| Normal-VS-KIRP CIMP |
3.54139995106806E-09 |
| Normal-VS-Unclassified PRCC |
1.62847513252018E-12 |
| Type1 PRCC-VS-Type2 PRCC |
4.038400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
5.077200E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
3.932000E-02 |
| Type2 PRCC-VS-KIRP CIMP |
6.998200E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
3.294600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.839000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
<1E-12 |
| Normal-vs-N1 |
9.12603326241879E-14 |
| Normal-vs-N2 |
1.52934999999577E-05 |
| N0-vs-N1 |
1.223650E-01 |
| N0-vs-N2 |
2.041800E-01 |
| N1-vs-N2 |
8.527800E-01 |
|
|
